CL

Clover Health Investments, Corp.

CLOVHealthcareNASDAQ

Healthcare Plans

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.92B
+40.3% YoY
Net Income
-$85.5M
-98.9% YoY
EBITDA
-$83.9M
-86.6% YoY
Free Cash Flow
$75.1M

Scan Results

Daily timeframe
DateIndicatorDetails
Jul 6 MACD Negative CrossoverHistogram -0.0215, negative momentum
Jul 4 MACD Negative CrossoverHistogram -0.0215, negative momentum
About Clover Health Investments, Corp.

Clover Health Investments, Corp. operates in the Healthcare Plans space. Clover Health Investments, Corp. Valued at $2.43B, CLOV is a mid-cap name in its sector. provides medicare advantage plans in the United States.

Key stats
Market Cap$2.43B
Fwd P/E46.20
EPS$-0.13
Beta2.42
52W Change+57.1%
ROE-16.9%
Analysis

Clover Health Investments, Corp. reports $203.5M in cash and $0 in total debt. The company generates $75.1M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -16.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $1.10B (2022) to $1.92B (2025), reflecting a 75% increase over the period.

With a beta above 1.5, CLOV tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Clover Health Investments, Corp. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms